Which HIV Treatment is Best for Patients with HIV and Hepatitis C?
Juan Berenguer
REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JUAN BERENGUER, Hospital Gregorio Marañón, Madrid
A retrospective study has thrown doubt on the theory that protease inhibitors (PIs) are a preferable antiretroviral treatment for patients co-infected with HIV and Hepatitis C virus. Previous research had suggested that PIs had a more beneficial effect on liver fibrosis than NNRTIs, but a study based at the Hospital Gregorio Marañón in Madrid has found the opposite. Derek Thorne discussed the data with Juan Berenguer.
JUAN BERENGUER, Hospital Gregorio Marañón, Madrid
A retrospective study has thrown doubt on the theory that protease inhibitors (PIs) are a preferable antiretroviral treatment for patients co-infected with HIV and Hepatitis C virus. Previous research had suggested that PIs had a more beneficial effect on liver fibrosis than NNRTIs, but a study based at the Hospital Gregorio Marañón in Madrid has found the opposite. Derek Thorne discussed the data with Juan Berenguer.
Dr. Juan Berenguer
Reciba un cordial saludo, no sé si sea éste el medio para comunicarme con usted, soy odontologo con espcialidad en cirugía oral, egresado de la Universidad de Guadalajara, en Guadalajara, Jalisco. México, cuando estube en el internado de la especialidad realice un estudio bibliográfico sobre el SIDA en cavidad oral, me gustaría contactarlo y conocerle, quiciera saber más sobre el tema ampliar mis conocimientos, si usted gusta le puedo envíar mi CV.
Mil gracias de antemano y espero recibir su información, no sé por que medio puedo enviarle mi correo electrónico…